BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 6214441)

  • 21. Cardiovascular, sedative and anticholinergic effects of amitriptyline and zimelidine in young and elderly volunteers.
    Swift CG; Haythorne JM; Clarke P; Stevenson IH
    Acta Psychiatr Scand Suppl; 1981; 290():425-32. PubMed ID: 6452804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double blind study comparing the efficacy of zimelidine and amitriptyline in endogenous depression.
    O'Connor M; Grigor J
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):127-32. PubMed ID: 6233635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between zimelidine and desipramine in endogenous depression. A cross-over study.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Aug; 66(2):129-38. PubMed ID: 6215831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zimeldine versus amitriptyline in endogenous depression. A double-blind study with special reference to effects on liver function.
    Larsen FW; Hansen CE
    Acta Psychiatr Scand; 1984 Apr; 69(4):343-9. PubMed ID: 6232828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crossover study of zimelidine and desipramine in depression: evidence for amine specificity [proceedings].
    Potter WZ; Calil HM; Extein I; Muscettola G; Goodwin FK
    Psychopharmacol Bull; 1981 Jan; 17(1):26-9. PubMed ID: 6453356
    [No Abstract]   [Full Text] [Related]  

  • 26. Zimelidine - a serotonin uptake blocker in the treatment of phobic anxiety.
    Evans L; Best J; Moore G; Cox J
    Prog Neuropsychopharmacol; 1980; 4(1):75-9. PubMed ID: 6447309
    [No Abstract]   [Full Text] [Related]  

  • 27. Zimelidine: a new antidepressive.
    Drug Ther Bull; 1982 Nov; 20(24):95-6. PubMed ID: 6217059
    [No Abstract]   [Full Text] [Related]  

  • 28. Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Heel RC; Morley PA; Brogden RN; Carmine AA; Speight TM; Avery GS
    Drugs; 1982 Sep; 24(3):169-206. PubMed ID: 6215240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of EEG sleep, antidepressants, and affective disease.
    Kupfer D
    J Clin Psychiatry; 1982 Nov; 43(11 Pt 2):30-6. PubMed ID: 6217197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trials with new bicyclic and tetracyclic compounds: zimelidine and maprotiline [proceedings].
    Claghorn JL; Mathew RJ
    Psychopharmacol Bull; 1981 Jan; 17(1):23-6. PubMed ID: 6453355
    [No Abstract]   [Full Text] [Related]  

  • 31. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Acta Psychiatr Scand; 1982 Jul; 66(1):66-82. PubMed ID: 6181652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind comparison of bupropion and amitriptyline in depressed inpatients.
    Davidson J; Miller R; Van Wyck Fleet J; Strickland R; Manberg P; Allen S; Parrott R
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):115-7. PubMed ID: 6406438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind study of minaprine versus amitriptyline in major depression.
    Del Zompo M; Bernardi F; Burrai C; Bocchetta A
    Neuropsychobiology; 1990-1991; 24(2):79-83. PubMed ID: 2134115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A controlled double-blind study of femoxetine and amitriptyline in patients with endogenous depression.
    Reebye PN; Yiptong C; Samsoon J; Schulsinger F; Fabricius J
    Pharmacopsychiatria; 1982 Sep; 15(5):164-9. PubMed ID: 6757983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zimelidine to geriatric patients: a pharmacokinetic and clinical study.
    Dehlin O; Björnsson G; Lundström J
    Acta Psychiatr Scand Suppl; 1981; 290():410-24. PubMed ID: 6452803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The treatment of phobic anxiety by zimelidine.
    Evans L; Moore G
    Acta Psychiatr Scand Suppl; 1981; 290():342-5. PubMed ID: 6452800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
    Smith WT; Glaudin V; Panagides J; Gilvary E
    Psychopharmacol Bull; 1990; 26(2):191-6. PubMed ID: 2236455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
    Feighner JP
    J Clin Psychiatry; 1985 Sep; 46(9):369-72. PubMed ID: 3897204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zimelidine: a therapeutic and pharmacokinetic study in depression.
    Coppen A; Ramo Rao VA; Swade C; Wood K
    Psychopharmacology (Berl); 1979 Jun; 63(3):199-202. PubMed ID: 113803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind study of the efficacy and safety of dothiepin hydrochloride in the treatment of major depressive disorder.
    Stratas NE
    J Clin Psychiatry; 1984 Nov; 45(11):466-9. PubMed ID: 6386793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.